JD Ziegler - Asensus Surgical Vice Sales

Executive

JD Ziegler is Vice Sales of Asensus Surgical
Age 50
Phone919 765 8400
Webhttps://www.asensus.com

Asensus Surgical Management Efficiency

The company has return on total asset (ROA) of (0.7618) % which means that it has lost $0.7618 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.3402) %, meaning that it created substantial loss on money invested by shareholders. Asensus Surgical's management efficiency ratios could be used to measure how well Asensus Surgical manages its routine affairs as well as how well it operates its assets and liabilities.
Asensus Surgical currently holds 5.68 M in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Asensus Surgical has a current ratio of 10.99, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Asensus Surgical's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Jonathan JDBionano Genomics
49
Sheila MBABionano Genomics
N/A
Klint RoseBionano Genomics
N/A
Eliyahu YoreshForesight Autonomous Holdings
54
Eliyahu CPAForesight Autonomous Holdings
54
Carol MBAJaguar Animal Health
60
Dror ElbazForesight Autonomous Holdings
45
Izac AssiaForesight Autonomous Holdings
52
Cory KreeckBionano Genomics
N/A
Gulsen MBABionano Genomics
51
Kenneth HortonSenseonics Holdings
57
Oren BarOnForesight Autonomous Holdings
52
Sivan ScherfForesight Autonomous Holdings
37
Karen BrunkeJaguar Animal Health
72
Peter HodgeJaguar Animal Health
N/A
Catherine CollisJaguar Animal Health
N/A
Kenneth JDSenseonics Holdings
57
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery in the United States, Europe, and Asia. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. Asensus Surgical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 153 people. Asensus Surgical (ASXC) is traded on NYSE MKT Exchange in USA and employs 207 people.

Management Performance

Asensus Surgical Leadership Team

Elected by the shareholders, the Asensus Surgical's board of directors comprises two types of representatives: Asensus Surgical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Asensus. The board's role is to monitor Asensus Surgical's management team and ensure that shareholders' interests are well served. Asensus Surgical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Asensus Surgical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ethan Loiselle, Vice Marketing
Joshua Weingard, Chief Secretary
Ravi Kommineni, Head Regulatory
MBA CA, Ex CFO
JD Ziegler, Vice Sales
Motti Frimer, Digital RD
Anthony Fernando, CEO President
Amanda Owens, Global People
Stephanie Fitts, Quality Clinical

Asensus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Asensus Surgical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Consideration for investing in Asensus Stock

If you are still planning to invest in Asensus Surgical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asensus Surgical's history and understand the potential risks before investing.
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance